Agilent Technologies Inc (NYSE:A) Holdings Boosted by Bessemer Group Inc.

Bessemer Group Inc. boosted its position in shares of Agilent Technologies Inc (NYSE:A) by 2.9% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 261,090 shares of the medical research company’s stock after purchasing an additional 7,376 shares during the period. Bessemer Group Inc. owned 0.08% of Agilent Technologies worth $19,495,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Destination Wealth Management grew its holdings in shares of Agilent Technologies by 100.0% during the 1st quarter. Destination Wealth Management now owns 400 shares of the medical research company’s stock valued at $32,000 after acquiring an additional 200 shares in the last quarter. Lake Point Wealth Management bought a new stake in Agilent Technologies in the fourth quarter worth $30,000. Financial Gravity Wealth Inc. bought a new stake in Agilent Technologies in the first quarter worth $52,000. Knuff & Co LLC boosted its holdings in Agilent Technologies by 203.3% in the first quarter. Knuff & Co LLC now owns 910 shares of the medical research company’s stock worth $73,000 after purchasing an additional 610 shares in the last quarter. Finally, NEXT Financial Group Inc boosted its holdings in Agilent Technologies by 22.0% in the second quarter. NEXT Financial Group Inc now owns 925 shares of the medical research company’s stock worth $69,000 after purchasing an additional 167 shares in the last quarter.

A number of brokerages recently issued reports on A. Barclays set a $330.00 price objective on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Monday, July 15th. Wolfe Research began coverage on shares of Waters in a report on Thursday, May 30th. They issued an “underperform” rating for the company. Bank of America upgraded shares of First Horizon National from an “underperform” rating to a “neutral” rating and set a $16.00 price objective for the company in a report on Tuesday, July 16th. Zacks Investment Research upgraded shares of Golub Capital BDC from a “hold” rating to a “buy” rating and set a $20.00 price objective for the company in a report on Tuesday, July 16th. Finally, Piper Jaffray Companies set a $29.00 price objective on shares of Bausch Health Companies and gave the stock a “buy” rating in a report on Tuesday, June 11th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have given a buy rating to the stock. Agilent Technologies presently has an average rating of “Buy” and an average target price of $83.92.

Agilent Technologies stock traded up $0.71 on Tuesday, reaching $69.80. 199,122 shares of the stock were exchanged, compared to its average volume of 2,306,350. The firm has a market cap of $21.88 billion, a PE ratio of 25.04, a PEG ratio of 1.91 and a beta of 1.41. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.82 and a current ratio of 3.41. Agilent Technologies Inc has a twelve month low of $61.01 and a twelve month high of $82.27. The company’s fifty day moving average is $71.77.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Tuesday, May 14th. The medical research company reported $0.71 EPS for the quarter, missing the Zacks’ consensus estimate of $0.72 by ($0.01). The company had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.27 billion. Agilent Technologies had a net margin of 22.25% and a return on equity of 19.71%. The firm’s quarterly revenue was up 2.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.65 EPS. Equities analysts anticipate that Agilent Technologies Inc will post 3.05 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 24th. Stockholders of record on Tuesday, July 2nd will be given a dividend of $0.164 per share. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.94%. The ex-dividend date is Monday, July 1st. Agilent Technologies’s dividend payout ratio is currently 23.66%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Article: Moving Average Convergence Divergence (MACD)

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.